# Fulgent Genetics, Inc.: filings

FLGT · Nasdaq · CIK 1674930 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/flgt.md) · [Financials](/companies/flgt/financials.md) · [Filings](/companies/flgt/filings.md) · [Insiders](/companies/flgt/insiders.md)

## Reports and events: 142 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 381, 8-K 77, 144 41, 10-Q 30, 3 13, CORRESP 12, DEF 14A 11, 10-K 10, UPLOAD 10, 424B5 7, SC 13G/A 7, DEFA14A 6, 4/A 5, S-8 5, SC 13D/A 5, SCHEDULE 13G/A 4, ARS 3, EFFECT 3, S-1/A 3, SC 13D 3, SC 13G 3, 144/A 2, 5 2, DRS/A 2, FWP 2, PRE 14A 2, S-3 2, SCHEDULE 13D/A 2, 424B4 1, 8-A12B 1, CERTNAS 1, CT ORDER 1, DRS 1, S-1 1, S-3/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-07-30 | 16:13 ET | [10-Q](/filings/0001193125-26-326136.md) | Quarterly report, period 2026-06-30 | 0001193125-26-326136 |
| 2026-07-30 | 16:09 ET | [8-K](/filings/0001193125-26-326119.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-326119 |
| 2026-06-02 | 19:07 ET | [8-K](/filings/0001674930-26-000028.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001674930-26-000028 |
| 2026-05-27 | 19:42 ET | [SCHEDULE 13D/A](/filings/0001302110-26-000020.md) | Ownership report, active investor, amended | 0001302110-26-000020 |
| 2026-05-21 | 17:04 ET | [8-K](/filings/0001674930-26-000025.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001674930-26-000025 |
| 2026-05-14 | 16:27 ET | [8-K](/filings/0001193125-26-224147.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-224147 |
| 2026-05-01 | 07:08 ET | [10-Q](/filings/0001193125-26-199065.md) | Quarterly report, period 2026-03-31 | 0001193125-26-199065 |
| 2026-05-01 | 07:03 ET | [8-K](/filings/0001193125-26-199061.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-199061 |
| 2026-03-31 | 16:55 ET | [SCHEDULE 13D/A](/filings/0001302110-26-000013.md) | Ownership report, active investor, amended | 0001302110-26-000013 |
| 2026-03-31 | 16:11 ET | [DEF 14A](/filings/0001674930-26-000020.md) | Proxy statement, period 2026-03-31 | 0001674930-26-000020 |
| 2026-03-17 | 16:36 ET | [8-K](/filings/0001674930-26-000012.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001674930-26-000012 |
| 2026-02-27 | 07:15 ET | [10-K](/filings/0001193125-26-079169.md) | Annual report, period 2025-12-31 | 0001193125-26-079169 |
| 2026-02-27 | 07:04 ET | [8-K](/filings/0001193125-26-079152.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-079152 |
| 2025-12-22 | 16:11 ET | [8-K](/filings/0001193125-25-328747.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-328747 |
| 2025-11-07 | 07:14 ET | [10-Q](/filings/0001193125-25-271013.md) | Quarterly report, period 2025-09-30 | 0001193125-25-271013 |
| 2025-11-07 | 07:10 ET | [8-K](/filings/0001193125-25-271006.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-271006 |
| 2025-10-20 | 06:04 ET | [8-K](/filings/0001193125-25-242917.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-242917 |
| 2025-08-01 | 07:09 ET | [10-Q](/filings/0000950170-25-101105.md) | Quarterly report, period 2025-06-30 | 0000950170-25-101105 |
| 2025-08-01 | 07:05 ET | [8-K](/filings/0000950170-25-101103.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-101103 |
| 2025-05-15 | 16:17 ET | [8-K](/filings/0000950170-25-072676.md) | 5.07 Shareholder vote results | 0000950170-25-072676 |
| 2025-05-02 | 07:14 ET | [10-Q](/filings/0000950170-25-062258.md) | Quarterly report, period 2025-03-31 | 0000950170-25-062258 |
| 2025-05-02 | 07:10 ET | [8-K](/filings/0000950170-25-062257.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-062257 |
| 2025-03-25 | 16:17 ET | [DEF 14A](/filings/0000950170-25-044407.md) | Proxy statement, period 2025-03-25 | 0000950170-25-044407 |
| 2025-02-28 | 07:15 ET | [10-K](/filings/0000950170-25-029512.md) | Annual report, period 2024-12-31 | 0000950170-25-029512 |
| 2025-02-28 | 07:10 ET | [8-K](/filings/0000950170-25-029510.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-029510 |
| 2024-11-08 | 07:17 ET | [10-Q](/filings/0000950170-24-123684.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123684 |
| 2024-11-08 | 07:10 ET | [8-K](/filings/0000950170-24-123681.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-123681 |
| 2024-11-05 | 16:46 ET | [SC 13D/A](/filings/0000950170-24-121578.md) | Ownership report, active investor, amended | 0000950170-24-121578 |
| 2024-08-02 | 07:38 ET | [10-Q](/filings/0000950170-24-089592.md) | Quarterly report, period 2024-06-30 | 0000950170-24-089592 |
| 2024-08-02 | 07:09 ET | [8-K](/filings/0000950170-24-089587.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-089587 |
| 2024-05-16 | 16:29 ET | [8-K](/filings/0000950170-24-061120.md) | 5.07 Shareholder vote results | 0000950170-24-061120 |
| 2024-05-03 | 07:34 ET | [10-Q](/filings/0000950170-24-052485.md) | Quarterly report, period 2024-03-31 | 0000950170-24-052485 |
| 2024-05-03 | 07:05 ET | [8-K](/filings/0000950170-24-052481.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-052481 |
| 2024-03-27 | 16:05 ET | [DEF 14A](/filings/0000950170-24-037159.md) | Proxy statement, period 2024-03-27 | 0000950170-24-037159 |
| 2024-02-28 | 17:03 ET | [10-K](/filings/0000950170-24-022233.md) | Annual report, period 2023-12-31 | 0000950170-24-022233 |
| 2024-02-28 | 07:08 ET | [8-K](/filings/0000950170-24-021645.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-021645 |
| 2023-11-03 | 07:31 ET | [10-Q](/filings/0000950170-23-058512.md) | Quarterly report, period 2023-09-30 | 0000950170-23-058512 |
| 2023-11-03 | 07:09 ET | [8-K](/filings/0000950170-23-058509.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-058509 |
| 2023-08-04 | 07:14 ET | [10-Q](/filings/0000950170-23-038316.md) | Quarterly report, period 2023-06-30 | 0000950170-23-038316 |
| 2023-08-04 | 07:07 ET | [8-K](/filings/0000950170-23-038312.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-038312 |
| 2023-05-18 | 16:05 ET | [8-K](/filings/0000950170-23-023014.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-23-023014 |
| 2023-05-05 | 07:24 ET | [10-Q](/filings/0000950170-23-018079.md) | Quarterly report, period 2023-03-31 | 0000950170-23-018079 |
| 2023-05-05 | 07:05 ET | [8-K](/filings/0000950170-23-018076.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-018076 |
| 2023-03-31 | 16:10 ET | [DEF 14A](/filings/0000950170-23-011376.md) | Proxy statement | 0000950170-23-011376 |
| 2023-02-28 | 16:49 ET | [10-K](/filings/0000950170-23-005178.md) | Annual report, period 2022-12-31 | 0000950170-23-005178 |
| 2023-02-28 | 16:24 ET | [8-K](/filings/0000950170-23-005124.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-005124 |
| 2023-01-12 | 16:10 ET | [8-K](/filings/0000950170-23-000716.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-23-000716 |
| 2023-01-03 | 16:11 ET | [8-K](/filings/0000950170-23-000048.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-000048 |
| 2022-11-23 | 16:09 ET | [8-K](/filings/0000950170-22-025666.md) | 3.01 Delisting notice | 0000950170-22-025666 |
| 2022-11-10 | 21:38 ET | [SC 13D/A](/filings/0001564590-22-037265.md) | Ownership report, active investor, amended | 0001564590-22-037265 |

Page 1 of 3. [Older](/companies/flgt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.